Background: Cryptorchidism and hypospadias are common problems in males attending the pediatric surgery clinic. These two abnormalities are also associated with genetic syndromes/disorders of sexual development (DSD). Aims and Objectives: Aim of present study was to find out the prevalence of SRY and DAX-1 gene deletions in phenotypic males with cryptorchidism or hypospadias. Materials and methods: Children with cryptorchidism, or hypospadias attending the Pediatric Surgery OPD were enrolled for the study after informed consent. One blood sample (4ml) was taken from each patient for DNA analysis and PCR amplification of SRY and DAX-1 genes was done using the previously described primers. PCR for DAX and SRY genes was done according to a standard protocol. Results: The age ranged from 12 months to 144 months. Twentynine children had cryptorchidism and 22 had hypospadias. Out of 29 children having cryptorchidism, 11 had right side cryptorchidism and 7 had bilateral cryptorchidism. Out of 22 children having hypospadias, 13 had distal penile hypospadias. The DNA analysis showed amplification of DAX gene in all 51 patients. SRY gene showed amplification in 50/51 patients and one patient's DNA did not show amplification. Conclusion: More extensive studies are needed to explore the enigma of genetic basis involved in DSD. Cryptorchidism and hypospadias are anomalies with potentially severe consequences, such as infertility and testicular cancer, and more research efforts can help in characterization of cause of these abnormalities.
INTRODUCTION
Disorders of sexual development (DSD) are one of the most difficult disorders to understand, evaluate and to treat. The development in those candidates is influenced by multiple factors such as exposure to androgens, sex chromosome, genes, brain structures as well as social circumstances and family dynamics. Cryptorchidism is defined as testis that is not 4cm or more below the pubic tubercle in an infant of normal size. 1 It is most common congenital urogenital anomaly in newborn. Temporal analyses suggest an increasing secular trend in the incidence during the last decades in some countries. 2 However, there are still contrary reports. 3, 4 On the other hand, there is a general agreement on the seasonality of cryptorchidism with spring and autumn being the seasons of significantly highest (peak in March) and lowest (trough in September) incidence, respectively. 5, 6 Most researchers attribute the above phenomenon to analogous seasonal variations of sex hormones. Hypospadias is defined as arrest in the development of urethra spongiosum and ventral prepuce resulting in abnormal meatal opening on ventral surface of penis or perineum. The incidence is being 4-8/1000 live births. 7, 8 In developing countries like India, Pakistan and other southeast asian countries and as well as many African countries, due to lack of data no precise statement on incidence and prevalence may be given but due to its risk factors and awareness, its reporting is increasing. 9 Several genes are involved in normal development, differentiation, descent and function of gonads. Of these the SRY gene is most frequently studied. DAX-1 gene is present on the short arm of X chromosome-Xp21.3. Several studies had shown that this gene is not required for either testicular or ovarian differentiation but a double dose of DAX-1 functions as an antitestis gene. [10] [11] [12] [13] But recently it has been proposed that DAX functions as an early mediator of testis development down stream to SRY.
14 Moreover, it has been known that DSDs with the presence of the Y chromosome are associated with an increased risk for the development of Germ Cell Tumors. 15, 16 Cryptorchidism is also associated with decreased testicular function. In unilateral cryptorchidism, the incidence of infertility may be as high as 32% and up to 59% of men with bilateral cryptorchidism may be infertile despite surgical correction by orchidopexy. [17] [18] [19] So we planned to do this study mainly for role of SRY and DAX gene deletions in Indian children with cryptorchidism and hypospadias.
MATERIALS AND METHODS
Consecutive children with cryptorchidism, or hypospadias attending the Pediatric surgery outpatient clinic of PGIMER during the period of 01-01-2010 to 31-12-2010 who fulfilled the criteria were included in study after informed consent. One blood sample (4 ml) was taken from each patient in EDTA vial for DNA analysis. DNA PCR amplication was done using standard methods using previously described primers ( Table 1 ).The gels were visualized under gel documentation system of Alpha Innotech Corporation.
RESULTS
Fifty-one children from different states surrounding Chandigarh were enrolled in the study. 20 were from Punjab, 12 were from Haryana, 8 were from Chandigarh, 4 were from Uttarakhand, 3 from Uttar Pradesh, 3 were from Himachal Pradesh and 1 from Bihar. The age ranged from 12 months to 144 months. Twenty-nine children had cryptorchidism and 22 had hypospadias. Out of 29 children having cryptorchidism, 11 had right side cryptorchidism, 11 had left side cryptorchidism, 7 had bilateral cryptorchidism ( Figure 1) . Out of 22 children having hypospadias, 13 had distal penile hypospadias, 9 had proximal penile hypospadias. Twelve children of cryptorchidism and nine children of hypospadias also had short stature ( Figure 2 ). There was no family history of infertility or mental retardation in any of the enrolled children. PCR amplification of DAX gene ( Figure  3 ) showed product of 601 base pairs in all 51 patients. PCR for SRY gene was done which showed amplification at 470 base pairs in 50 patients ( Figure 4 ) and one patient's DNA did not show amplification ( Figure 5 ).This was a child with cryptorchidism ( Table 2) . The DNA quality was rechecked by running on gel and spectrophotometry. Sample has been sent for complete gene sequencing. 
DISCUSSION
Recently, terms like hermaphroditism, pseudoher maproditism, ambiguous genitalia are considered controversial. In recent years, the terminology 'disorders of sexual development (DSD)' is being increasingly used. This includes all the conditions of abnormal sexual development and differentiation. 20 SRY acts by binding of the HMG box to a 6bp DNA sequence which bends DNA through a specific angle according to Harley et al 1992.This may promote association of regulatory elements bound to a far-flung region of DNA forming complex controls the activity of other genes. SRY gene is transcribed in many embryonic tissues which is then limited to testis after birth. It is a complex process by which SRY controls other genes.
21 DAX 1 antagonises MIS expression during the male sexual development by inhibiting the synergistic interaction of SF1,WT1,factors that act to promote MIS.
22
The role of genes like WT1, SOX9, SRYetc. in the development of primordial gonads is depicted in (Figure 6 ). A study done in Australia had used the Affymetrix Genome-Wide Human SNP Array 6.0 to analyse copy number variation in 23 individuals with unexplained 46, XY DSD due to gonadal dysgenesis (GD). They described three discrete changes in copy number that are the likely cause of the GD. Firstly, a large duplication on the X chromosome that included DAX1 (NR0B1). Secondly, a rearrangement that appears to affect a novel gonad-specific regulatory region in a known testis gene, SOX9. Functional analysis of potential SRY binding sites within this deleted region identified five putative enhancers, suggesting that sequences additional to the known SRY-binding TES (Testis Specific Enhancer) enhancer influence human testis-specific SOX9 expression. Thirdly, a small deletion immediately downstream of GATA4, supporting a role for GATA4 in gonad development in humans. These CNV analyses give new insights into the pathways involved in human gonad development and dysfunction, and suggest that rearrangements of non-coding sequences disturbing gene regulation may account for significant proportion of DSD cases. They could not find any deletion in SRY gene of 23 patients.
23 DAX-1 is required for both adrenal and gonadal development. It is expressed throughout the development of adrenals and its deletion results in AHC (Adrenal Hypoplasia Congenita). Hypogonadotropic hypogonadism is associated with AHC because DAX1 is also expressed in developing hypothalamus. 24 The common embryological origin of gonads and adrenal glands and the localization of DAX1 within the DSS critical region on X chromosome, suggested that DAX1 might correspond to DSS. Because XY individuals deleted for DSS develop as males it can be proposed that DAX1 is required for ovarian but not testicular development and that its action should be turned off in XY genital ridge to avoid interference with testis development. 25 A study done in Italy by Barbaro M, et al in 2008 had shown in 46 XY gonadal dysgenesis identified two copy number variations, duplication of DAX1 gene, indicaing that DAX 1 is not required for the development of testis. But recent studies done in mice model suggest that DAX1 is required for the development of testis. A study done by Bouma et al. in Boston had shown evidence in mice that DAX1 plays an early essential role in fetal testis development. 26 They hypothesised that upregulation of SOX9 expression in precursor somatic cells, a process required for their differentiation as sertoli cells, depends on the coordinated expression of DAX1, SRY and other genes. Studies on mice had shown that DAX acts as an important player in male sex determination in a position after SRY induction and before SOX upregulation. The gene targets are FGF9 (Fibroblast Growth Factor 9), Neurotropin3 (NTF3). The deletion of DAX1 lead to decreased amount of the above said targets and resulted in XY gonadal dysgenesis. 27 In literature we could not able to find any study on humans supporting DAX 1 as a "Protestis" gene. Here we tried to briefly describe the mechanism of cryptorchidism and hypospadias. Gonads are positioned between two structures, the cranial suspensory ligament and gubernaculum and descent is divided into two phases-(1) transabdominal and (2) inguinoscrotal. There are few human studies for isolated cryptorchidism or hypospadias for SRY, DAX-1 gene deletion.
Several AZF (Azoospermic factor) abnormalities have been reported in males with infertility. SF1(NR5A1) mutations have been reported in 46 XY individuals with severe penoscrotal hypospadias. 28 An earlier study which was done by Bashamboo A et al, to study the sex chromosomal anamolies reported a patient with isolated cryptorchidism with SRY gene deletion, however some other patients in the same study did not have SRY deletion.
29
Another study has reported 46 XX male who presented with cryptorchidism, had Y chromosome fragment transferred to short arm of X-chromosome which might be telling the importance of SRY gene. Another study done was showing deletion in SRY promoter region in patient with severe hypospadias without cryptorchidism who has undergone 18 surgeries. 30 DAX-1 deletion has been seen in XX males and mutations are also reported in patients with X linked adrenal hypoplasia congenital.
31
DAX-1 mutations in other DSD phenotypes have not been well studied. DSD is one of the most difficult topics to understand. Cryptorchidism has been reported in 1.5-4.0% of fathers and 6.2% of brothers of cryptorchid subjects. 32 But in our patients there was no family history of cryptorchidism. Only one study has reported a Yq deletion involving the entirety of the long arm in one cryptorchid subject; also in that case both testes were undescended, and other features were present (such as small chin, high palate,mental retardation). 33 The SRY gene on the Y chromosome is the master switch for the determination of a testis, but other factors such as Wilms tumor 1 (WT1), SRY-box 9 (SOX9), Steroidogenic factor 1(SF1), DAX1, wingless-type mouse mammary 453 tumor virus integration site family, member 4(WNT4), required for testis development. Our study showed deletion of SRY gene in one patient, out of 51 which is approximately 2%, consistent with the previous studies. A previous study by Bashamboo et al had also found SRY gene deletion in a patient with isolated cryptorchidism.
29
A defect in any of these factors may lead to 46, XY gonadal disorder of sex development (DSD) including gonadal agenesis, dysgenesis and testicular regression. The first candidate gene to be analyzed in cases of 46, XY gonadal dysgenesis is SRY. However, mutations in the SRY gene accounts for only 10-15% of patients with 46, XY gonadal dysgenesis. 25 The consequence of absent or not fully functional testes is an absent or reduced production of testosterone and AMH that leads to the formation of female genitalia or ambiguous external genitalia depending on the degree of the defect. Multiple other genes are likely to be involved the 46XY DSDs other than SRY gene such as Insuline like3/relaxin like factor gene.
34 DAX1 shows sexually dimorphic gonadal expression. It is down regulated in the developing testis. Studies in mouse models support DAX1 as having both pro-testis and anti-testis functions. 14, 24, 26 These studies indicate that a critical level of DAX1 is required for proper testis cord formation-levels above or below this level interfere with the early stages of testicular differentiation (e.g, a duplication interferes with SRY function, while a loss of function retards early cord organization on a susceptible genetic background). As testis development proceeds, DAX1 is down-regulated, that is it antagonises the SF1/WT1/SOX9 activation of AMH. Hence, DAX1 has dynamic effects on the developing testis that changes over time. 27 However, in our study we could not find any deletion in DAX (exon 2) gene in any of the patients with either cryptorchidism or hypospadias, suggesting that further studies of DAX gene are required.
In our study, 43% of the enrolled children had short stature which is likely multifactorial involving genetic and environmental factors. Some genetic syndromes associated with genital abnormalities include Facio Genital Dysplasia (FGD), Smith Lemli Opitz syndrome, MURCs associations, Noonan syndrome and WAGR syndrome. WT1 gene, implicated in WAGR syndrome is relatively well studied gene. Further research would give more insights into whether genes involved in these syndromes can also lead to isolated genital abnormality as part of minimal expression of the genetic defect.
CONCLUSION
Pathogenesis of DSDs is still not fully understood all across the globe. Our's is a pilot study with limited sample size. As the geographical, environmental factors may affect the phenotypic expression of genes, more and extensive studies are needed to explore the enigma of multiple genetic factors involved in DSD in Indian scenario. Epigenetic effects or associations may alter expression or presentation of abnormal gene in the gonadal pathways.
